M&As this week: JHL Biotech, Bio Techne, Metabolon
JHL Biotech has acquired 40% stake in a biomedical company based in Wuhan, China, in a long-term investment pursuit.
The acquirer company is a biopharmaceutical company based in Taiwan.
US-based life science company Bio Techne has completed the acquisition of Trevigen.
The acquisition was completed in an all-cash transaction and is expected to complement the acquirer company’s product portfolio, as well as be accretive to its adjusted earnings per share in the next financial year.
Also based in the US, the target company is a biotechnology company.
US-based health technology company Metabolon has acquired Metabolomic Discoveries, with the aim of advancing its European presence in metabolomics.
Based in Germany, the target company provides metabolomics and diagnostics services.